Michael Kothe - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Michael Kothe

Showing results (11-20 of 14) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 14 results.

Biochemistry|April 28, 2007

Structure of the catalytic domain of human polo-like kinase 1Michael Kothe, Darcy Kohls, Simon Low, et al.

Cell Death & Disease|October 24, 2020

CSF1R signaling is a regulator of pathogenesis in progressive MSNellwyn Hagan, John L Kane, Deepak Grover, et al.

ACS Medicinal Chemistry Letters|May 15, 2024

Identification of Selective Imidazopyridine CSF1R InhibitorsJohn L Kane, Gary Asmussen, Joseph Batchelor, et al.

ACS Medicinal Chemistry Letters|October 16, 2020

Discovery of Selective, Covalent FGFR4 Inhibitors with Antitumor Activity in Models of Hepatocellular CarcinomaHaibo Liu, Deqiang Niu, Robert Tjin Tham Sjin, et al.

Pageof 2

Search research articles

Showing results (11-20 of 14) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 14 results.

Biochemistry|April 28, 2007

Structure of the catalytic domain of human polo-like kinase 1Michael Kothe, Darcy Kohls, Simon Low, et al.

Cell Death & Disease|October 24, 2020

CSF1R signaling is a regulator of pathogenesis in progressive MSNellwyn Hagan, John L Kane, Deepak Grover, et al.

ACS Medicinal Chemistry Letters|May 15, 2024

Identification of Selective Imidazopyridine CSF1R InhibitorsJohn L Kane, Gary Asmussen, Joseph Batchelor, et al.

ACS Medicinal Chemistry Letters|October 16, 2020

Discovery of Selective, Covalent FGFR4 Inhibitors with Antitumor Activity in Models of Hepatocellular CarcinomaHaibo Liu, Deqiang Niu, Robert Tjin Tham Sjin, et al.

Pageof 2